Agenus BEST

Our goal is to treat cancers with novel combinations

Start : N/A End : N/A

Agenus is an immuno-oncology company designed to deliver innovation with speed for patients with cancer. We have a unique portfolio of antibodies, vaccines, cell therapies (through our AgenTus Therapeutics subsidiary) and adjuvants designed to treat cancers with optimal combinations.


 

Details

. Symbol  -  BEST

. Fundraising goal  -  $100,000,000

. Min. investment  -  $0

Project Team:

Garo Armen, PhD
Garo Armen, PhD

Chairman and CEO

Jennifer Buell, PhD
Jennifer Buell, PhD

Chief Operating Officer

Julie DeSander
Julie DeSander

Vice President, Business Development and Alliance Management

Anna Wijatyk, MD
Anna Wijatyk, MD

Vice President of Clinical Development

Sunil Gupta
Sunil Gupta

Vice President of Regulatory & Pharmacovigilance

Alex Duncan
Alex Duncan

Chief Technology Officer

Christian Cortis
Christian Cortis

Chief Strategy Officer & Head of Finance

Evan Kearns
Evan Kearns

Vice President & General Counsel

Christine Klaskin
Christine Klaskin

Vice President, Finance & Principal Accounting Officer

Garo H. Armen
Garo H. Armen

Chairman and CEO

Brian Corvese
Brian Corvese

Board of Directors

Wadih Jordan
Wadih Jordan

Board of Directors

Ulf Wiinberg
Ulf Wiinberg

Board of Directors

Timothy R. Wright
Timothy R. Wright

Board of Directors

Allison Jeynes-Ellis
Allison Jeynes-Ellis

Board of Directors

Advisors:

Robert Stein
Robert Stein

Senior R&D Advisor

Hagop Youssoufian
Hagop Youssoufian

Senior Clinical Strategist

Tyler Curiel
Tyler Curiel

Senior Strategist for Translational and Biomarker Development

Social media sites:

Comments

Popular STOs